【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q4 2012 8
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q4 2012 8
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q4 2012 10
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q4 2012 11
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q4 2012 12
2.4.1 Abbott Completes Private Placement of Notes for $14.7 Billion 12
2.4.2 Roche Revises Offer Price to Acquire Illumina for Up to $8.2 Billion 12
2.4.3 UnitedHealth Group to Acquire 90% Stake in Amil Participacoes for $4.9 Billion 12
2.4.4 HCA Completes Public Offering of Notes for $3.5 Billion 13
2.4.5 HCP Completes Acquisition of Senior Housing Portfolio of Emeritus and Blackstone for $1.7 Billion 13
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q4 2012 14
3.1.1 Top M&A Deals in Q4 2012 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q4 2011 – Q4 2012 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q4 2012 17
3.2.1 Top Initial Public Offerings in Q4 2012 18
3.2.2 Top Secondary Offerings in Q4 2012 18
3.2.3 Top PIPE Deals in Q4 2012 18
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q4 2011–Q4 2012 19
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q4 2011 – Q4 2012 20
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q4 2012 21
3.3.1 Top Venture Financing Deals in Q4 2012 22
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2012 23
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2012 24
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q4 2011 – Q4 2012 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Last Four Quarters 26
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 27
3.3.7 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q4 2012 28
3.3.8 Top Private Equity Deals in Q4 2012 29
3.3.9 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q4 2011 – Q4 2012 30
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2012 31
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2012 31
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q4 2011 – Q4 2012 33
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2012 34
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q4 2012 35
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q4 2012 35
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q4 2012 36
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2011 – Q4 2012 37
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q4 2011 – Q4 2012 38
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q4 2011 – Q4 2012 39
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2011 – Q4 2012 40
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q4 2012 41
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q4 2012 41
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q4 2011 – Q4 2012 42
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q4 2012 43
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q4 2012 43
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q4 2012 44
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q4 2011 – Q4 2012 45
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q4 2011 – Q4 2012 46
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2011 – Q4 2012 47
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2011 – Q4 2012 48
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q4 2011 – Q4 2012 49
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 50
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q4 2011 – Q4 2012 50
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q4 2011 – Q4 2012 51
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q4 2011 – Q4 2012 52
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q4 2011 – Q4 2012 53
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q4 2011 – Q4 2012 54
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q4 2011 – Q4 2012 55
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q4 2011 – Q4 2012 56
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 57
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q4 2012 57
7.1.1 Oncology – Deals of the Quarter 58
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q4 2012 59
7.2.1 Central Nervous System – Deals of the Quarter 60
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q4 2012 62
7.3.1 Infectious Disease – Deals of the Quarter 63
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q4 2012 64
7.4.1 Immunology – Deals of the Quarter 65
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q4 2012 66
7.5.1 Metabolic Disorders – Deals of the Quarter 67
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q4 2012 68
7.6.1 Cardiovascular – Deals of the Quarter 69
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q4 2012 70
7.7.1 Gastrointestinal – Deals of the Quarter 71
7.8 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q4 2012 72
7.8.1 Ophthalmology – Deals of the Quarter 73
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q4 2012 74
7.9.1 Respiratory – Deals of the Quarter 75
7.10 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q4 2012 76
7.10.1 Dermatology – Deals of the Quarter 77
8 Deal Summary by Geography 78
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q4 2012 78
8.1.1 North America – Deals of the Quarter 79
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q4 2012 81
8.2.1 Europe – Deals of the Quarter 82
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q4 2012 83
8.3.1 Asia-Pacific – Deals of the Quarter 84
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q4 2012 85
8.4.1 Rest of the World – Deals of the Quarter 86
9 Pharmaceuticals & Healthcare, Global, Top Advisors 87
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Last One Year 87
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Last One Year 88
10 Appendix 89
11 Further Information 93
11.1 Methodology 93
11.2 About GlobalData 93
11.3 Contact Us 94
11.4 Disclosure information 94
11.5 Disclaimer 94
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向（四半期別）：Q4 2012■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2012
■ 発行日：2013年1月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160305
■ 調査対象地域：グローバル
- 通信APIの世界市場予測（～2021年）“Increasing need for monetizing telecom carrier services is driving the smart education and learning market” The telecom Application Programming Interface (API) market size is estimated to grow from USD 93.69 billion in 2016 to USD 231.86 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 19.87%. Improving telecom API user experience, monetization of telecom operator services, rising dema …
- モジュール工法の世界市場：タイプ別（常設、再配置可能）、材料別（プレキャストコンクリート、鋼鉄、木材、プラスチック）、モジュール別、最終用途分野別、地域別予測Global Modular Construction Market to reach USD 149.4 billion by 2025. Global Modular Construction Market valued approximately USD 85 billion in 2017 is anticipated to grow with a healthy growth rate of more than 7.30% over the forecast period 2017-2025. Modular construction is prefabricated buildings that are manufactured in a plant. It offers significant advantages compared to conventional build …
- PHM(集団健康管理)の世界市場：製品別（ソフトウェア、サービス）、最終用途別（納税者、プロバイダ―、雇用者グループ）、地域別、セグメント予測The global population health management market size is expected to reach USD 101.0 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 20.7% during the forecast period. The need for population health services that combine multiple functionalities is increasing, due to the complex nature of care delivery and payment models. PHM solutions can …
- ハラール化粧品の世界市場2015-2019About Halal Cosmetics Halal is an Arabic term meaning permissible or lawful. Haram, which is the opposite of halal, means prohibited or unlawful according to Islamic law. Halal and Haram are universal words that apply to all facets of life, including halal banking, halal clothes, and halal food. These words are popularly used in relation to food products, meat products, cosmetics, personal care pr …
- 自動車用インテリジェントタイヤの世界市場2018-2022105 pages, November 2018 About this market Connected cars increase opportunities for developing advanced safety features that can alert, medical services, police authorities, and other vehicles regarding any issues or accidents occurred on the road. Also, the need for medical assistance can be automatically conveyed. Adoption of intelligent tires are expected to increase with the development of co …
- ピコ・プロジェクターの世界市場2015-2019About Pico Projector A projector is a portable optical device that projects images on any surface or screen. Traditional projector and pico projector are the two types of projector available; the latter is preferred over the former for its small size, light weight, and easy portability. There are two types of pico projector available in the market: standalone and embedded. Technavio's analysts for …
- 抗菌性包装の世界市場2016-2020：抗菌性プラスチック包装、抗菌性バイオポリマー包装、抗菌性板紙包装About Antimicrobial Packaging Antimicrobial packaging is an active technology packaging solution. Antimicrobial agents are active barrier agents that are added to packaging materials for making antimicrobial packaging materials. Antimicrobial packaging materials are used to prevent the penetration of small atmospheric and molecular gases, such as carbon dioxide, oxygen, volatile flavor nitrogen co …
- Enteric Diseases in Italy 2014: Market Outlook and Emerging OpportunitiesAbout This ReportThis new 322-page report from Venture Planning Group presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals and Commercial/Priv …
- 北米の使い捨てアイスパック市場：用途別、製品別、地域別Disposable Icepacks Market in North America: About this market Technavio’s disposable icepacks market in North America analysis considers sales from food and beverage, medical and healthcare, and chemical applications. Our study also finds the sales of disposable icepacks in the US, Canada, and Mexico. In 2019, the food and beverage segment had a significant market share, and this trend is expecte …
- ゴーゼビールの世界市場2018-2022About Gose Beer Gose is a top-fermented beer that originated in Goslar, Germany. It is brewed with at least 50% of the grain bill being malted wheat. Dominant flavors in gose include a lemon sourness, an herbal characteristic, and a strong saltiness (the result of either local water sources or added salt). Technavio’s analysts forecast the global gose beer market to grow at a CAGR of 28.68% during …
- 世界の医療放射線検出、モニタリング、安全市場The global radiation protection (detection, monitoring, and safety) market was valued at $920.0 million in 2012, and is expected to reach $1,231.2 million by 2017 at a CAGR of 6.0% from 2012 to 2017. The various industries covered in this report are healthcare, manufacturing, defense, nuclear power plants, homeland security, and others (waste management, mining, agriculture, and food irradiation). …
- 胆汁性肝硬変(Biliary Cirrhosis)の治療薬パイプライン動向（2015年上半期版）Biliary Cirrhosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Biliary Cirrhosis - Pipeline Review, H1 2015’, provides an overview of the Biliary Cirrhosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Biliary Cirrhosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism …
- Boston Scientific Corporation：市場シェア分析Boston Scientific Corporation Market Share Analysis Summary GlobalData’s new report, “Boston Scientific Corporation Market Share Analysis” provides in-depth information on Boston Scientific Corporation’s market position in the different medical equipment markets it operates in. The report provides Boston Scientific Corporation market share information in six key market categories – Remote Patient …
- 出版の世界市場：新聞発行、書籍発行、雑誌発行About Publishing Publishing refers to the process of communicating a set of information to the public through print, recording, TV, radio, or the internet. It involves writing, editing, and distributing content through print and digital medium. Publishing includes several industries such as education, banking and finance, music, government, and healthcare. In this report, we have considered only p …
- 合成ゼオライトの世界市場予測（～2023年）“Increasing demand for synthetic zeolites for use in specialty applications is expected to drive the overall growth of synthetic zeolites market.”The synthetic zeolites market is projected to grow from USD 5.2 billion in 2018 to USD 5.9 billion by 2023 at a Compound Annual Growth Rate (CAGR) of 2.6% during the forecast period. The growth of the synthetic zeolites market can be attributed to the in …
